How Kaposi's sarcoma herpesvirus packs its DNA
Dissecting the mechanism of herpesvirus genome packaging
Researchers are mapping how Kaposi's sarcoma-associated herpesvirus packs its genetic material to find new ways to stop the virus and help people with KSHV-related disease or weakened immune systems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11139649 on NIH RePORTER |
What this research studies
This project aims to figure out how the Kaposi's sarcoma-associated herpesvirus (KSHV) packages its DNA into new virus particles by studying the proteins and machinery that do the packing. Scientists will use advanced protein-analysis methods, high-resolution microscopy, and structural biology to see these components and determine their roles. They will also apply a new deep mutational scanning strategy to test how changes in viral proteins affect packaging and build a lab-based assay that recreates the packaging process. Together, these approaches are designed to reveal vulnerable viral steps that could be targeted by future antiviral drugs.
Who could benefit from this research
Good fit: People affected by Kaposi's sarcoma-associated herpesvirus infections—such as those with KSHV-related cancers or who are immunocompromised—are the patient groups most likely to benefit from eventual therapies informed by this research.
Not a fit: Patients without herpesvirus infections or whose conditions are unrelated to KSHV are unlikely to receive direct benefit from this laboratory-focused project.
Why it matters
Potential benefit: If successful, this work could identify new antiviral targets and lead to treatments that work differently from existing drugs and avoid common resistance problems.
How similar studies have performed: There has been promising progress with herpesviral packaging inhibitors, but solving the KSHV terminase structure and applying deep mutational scanning to this system is a newer, more detailed approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Didychuk, Allison Louise — Yale University
- Study coordinator: Didychuk, Allison Louise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.